Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03777215 · ClinicalTrials.gov registry record · Early Phase 1

Angiotensin-(1-7) and Energy Expenditure in Human Obesity

A Early Phase 1 study of Obesity, sponsored by Amy Arnold.

Active
Registry status
Early Phase 1
Development phase
30
Enrollment target
1
Study location

NCT03777215: Active Early Phase 1 study of Obesity, sponsored by Amy Arnold.

NCT03777215 is a Early Phase 1 study of Obesity that is active but no longer recruiting, run by Amy Arnold. The registered enrollment target is 30 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03777215, a Early Phase 1 study of Obesity, is active but no longer recruiting, sponsored by Amy Arnold.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to better define the role of the hormone angiotensin-(1-7) in energy balance. We will test the overall hypothesis that angiotensin-(1-7) increases resting energy expenditure and promotes markers of heat production (thermogenesis) in white adipose tissue in human obesity.

Conditions Studied

Obesity

Interventions

  • DRUG Saline
  • DRUG Angiotensin-(1-7)

Study Locations (1)

Pennsylvania

  • Penn State Milton S. Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-09-26
Est. Completion 2026-12
Phase Early Phase 1

Sponsor

Amy Arnold

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03777215

The ClinicalTrials.gov registry entry for NCT03777215 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The listed sponsor is Amy Arnold, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT03777215 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03777215 about?

NCT03777215 is a clinical study titled "Angiotensin-(1-7) and Energy Expenditure in Human Obesity". The objective of this study is to better define the role of the hormone angiotensin-(1-7) in energy balance. We will test the overall hypothesis that angiotensin-(1-7) increases resting energy expenditure and promotes markers of heat production (thermogenesis) in white adipose tissue in human obesit...

What is the current status of trial NCT03777215?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2019-09-26. Estimated completion is 2026-12.

What conditions does trial NCT03777215 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT03777215?

The interventions under investigation include: Saline (DRUG), Angiotensin-(1-7) (DRUG).

Who is sponsoring clinical trial NCT03777215?

This trial is sponsored by Amy Arnold, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03777215 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.